A Dark Vector Cognition product

Item 6. EXHIBITS

10K characters. Original on sec.gov ·

Item 6. EXHIBITS

The 5 tables in Item 6. EXHIBITS as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

2(i)Agreement and Plan of Merger, dated as of January 6, 2025, by and between Stryker Corporation and Inari Medical, Inc. – Incorporated by reference to Exhibit 2.1 the Company’s Form 8-K dated January 7, 2025 (Commission File No. 001-13149)
4(i)Thirty-Second Supplemental Indenture (including the form of the note), dated as of February 10, 2025, between Stryker Corporation and U.S. Bank Trust Company, National Association, as trustee – Incorporated by reference to Exhibit 4.2 to the Company’s Form 8-K dated February 10, 2025 (Commission File No.001-13149)
4(ii)Thirty-Third Supplemental Indenture (including the form of the note), dated as of February 10, 2025, between Stryker Corporation and U.S. Bank Trust Company, National Association, as trustee – Incorporated by reference to Exhibit 4.3 to the Company’s Form 8-K dated February 10, 2025 (Commission File No.001-13149)
4(iii)Thirty-Fourth Supplemental Indenture (including the form of the note), dated as of February 10, 2025, between Stryker Corporation and U.S. Bank Trust Company, National Association, as trustee – Incorporated by reference to Exhibit 4.4 to the Company’s Form 8-K dated February 10, 2025 (Commission File No.001-13149)
4(iv)Thirty-Fifth Supplemental Indenture (including the form of the note), dated as of February 10, 2025, between Stryker Corporation and U.S. Bank Trust Company, National Association, as trustee – Incorporated by reference to Exhibit 4.5 to the Company’s Form 8-K dated February 10, 2025 (Commission File No.001-13149)
19
STRYKER CORPORATION2025 First Quarter Form 10-Q
10(i)Credit Agreement, dated as of February 25, 2025, among Stryker Corporation, certain of its subsidiaries as designated borrowers, the various lenders and issuing banks party thereto, and Wells Fargo Bank, National Association, as administrative agent – Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K dated February 27, 2025 (Commission File No. 001-13149)
10(ii)Transition Agreement, dated January 24, 2025, between Stryker Corporation and Glenn S. Boehnlein – Incorporated by reference to Exhibit 10(xxxi) to the Company’s Form 10-K for the year ended December 31, 2024 (Commission File No. 001-13149)
10(iii)Letter Agreement, dated January 27, 2025, between Stryker Corporation and Preston Wells – Incorporated by reference to Exhibit 10.2 to the Company’s Form 8-K dated January 28, 2025 (Commission File No. 001-13149)
31(i)†Certification of Principal Executive Officer of Stryker Corporation pursuant to Rule 13a-14(a).
31(ii)†Certification of Principal Financial Officer of Stryker Corporation pursuant to Rule 13a-14(a).
32(i)††Certification by Principal Executive Officer of Stryker Corporation pursuant to 18 U.S.C. Section 1350.
32(ii)††Certification by Principal Financial Officer of Stryker Corporation pursuant to 18 U.S.C. Section 1350.
101.INSiXBRL Instance Document
101.SCHiXBRL Schema Document
101.CALiXBRL Calculation Linkbase Document
101.DEFiXBRL Definition Linkbase Document
101.LABiXBRL Label Linkbase Document
101.PREiXBRL Presentation Linkbase Document
104Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)
† Filed with this Form 10-Q
†† Furnished with this Form 10-Q
20
STRYKER CORPORATION2025 First Quarter Form 10-Q

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its

behalf by the undersigned thereunto duly authorized.

STRYKER CORPORATION
(Registrant)
Date:May 2, 2025/s/ KEVIN A. LOBO
Kevin A. Lobo
Chair, Chief Executive Officer and President
Date:May 2, 2025/s/ PRESTON W. WELLS
Preston W. Wells
Vice President, Chief Financial Officer

Previous: Item 40. 8(c) of Regulation S-K).